FDA Approves New Use for Cymbalta: Chronic Musculoskeletal Pain
Links shared publicly online about this topic.
- 744total visits
FDA Approves New Use for Cymbalta: Chronic Musculoskeletal Pain
View full resource at healthnews.com
Tags: Pain, Anxiety Medication, Antidepressant, Musculoskeletal, Fibromyalgia Medication, Neuropathic Pain Medication, FDA, Cymbalta
Most Recently Shared on November 7, 2010 at 3:04 pm By:
FDA Approves New Use for Cymbalta: Chronic Musculoskeletal Pain http://ht.ly/35IDB
FDA Approves Cymbalta for Chronic Musculoskeletal Pain
webmd.com — “A drug used to treat depression, anxiety, fibromyalgia, and diabetic neuropathy has been approved by the FDA for a new use -- to treat chronic musculoskeletal pain, including pain caused by osteoarthritis and chronic low back pain.” View full resource at webmd.com
Most Recently Shared on November 5, 2010 at 2:17 pm By:
FDA Approves Cymbalta for Chronic Musculoskeletal Pain http://bit.ly/9pH0fw
Eli Lilly's Cymbalta gets FDA nod for pain | Reuters
reuters.com — “NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain, including lower back pain and osteoarthritis.The” View full resource at reuters.com
Most Recently Shared on November 5, 2010 at 3:30 am By:
Eli Lilly's Cymbalta gets FDA nod for pain: NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulator... http://tinyurl.com/27cxlnk
Eli Lilly's Cymbalta gets FDA nod for pain | Reuters
reuters.com — “NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain, including lower back pain and osteoarthritis. The” View full resource at reuters.com
Most Recently Shared on November 5, 2010 at 3:00 am By:
Eli Lilly's Cymbalta gets FDA nod for pain http://dlvr.it/82yDg
UPDATE 2-FDA panel backs wider use of Eli Lilly's Cymbalta | Reuters
reuters.com — “* Eli Lilly's Cymbalta OK'd for chronic pain -FDA panel * Panelists split over back pain, arthritis use * Drugmaker seeking FDA approval to promote new use * FDA deadline passed, decision could come” View full resource at reuters.com
Most Recently Shared on August 20, 2010 at 3:59 pm By:
FDA panel supports Cymbalta for back pain, but not osteoarthritis http://www.reuters.com/article/idUSN1925181020100819 http://fb.me/FZGJbQkQ
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications - QualityPoint Technologies
qualitypointtech.net — “The Anesthetic and Life Support Drugs Advisory Committee which advises the FDA on whether to approve new drugs or alter their indications, has voted 8-6 in favor of expanding pain indications for Cymbalta (duloxetine HCl). The Committee's decision is not final - the FDA has to decide - however, the FDA usually goes along with what the Committee recommends. The Advisory Committee recommended the expanded use of Cymbalta for the treatment of chronic knee and lower back pain...” View full resource at qualitypointtech.net
Most Recently Shared on August 20, 2010 at 1:18 pm By:
Cymbalta (Duloxetine HCl) Approved By FDA Advisory Committee For Expanded Pain Indications: The Anesthetic and Lif... http://bit.ly/cEcF29
Advertisement

